This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.
Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
As a research and development-oriented global pharmaceutical company, we are always working to develop innovative new drugs, especially in areas where...
Advances continue to be made in technology and medicine that address unmet medical needs. However, there still remain barriers for many people who...
At Astellas, we recognize our Corporate Social Responsibility (CSR) as our responsibility for any...
Astellas believes that communication with stakeholders is crucial when considering how it will...
Astellas has established five fields of CSR-based management: Business Activities, Employees,...
Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving Non-Communicable Disease (NCD) care. Involving 22 biopharmaceutical companies, the initiative works with partners such as World Bank Group and the Union for International Cancer Control to help overcome a variety of access barriers to NCD medicines in low-income and lower-middle income countries. Access Accelerated will support multi-stakeholder dialogue and begin on-the-ground work to improve NCD prevention, diagnosis and treatment.
The “Story” section contains contents focused on “hero”: people (patients, employees, scientists, etc.), scientific innovation and social impact that enable Astellas to stand on the forefront of healthcare change, turning innovative science into value for patients. These stories reflect our business philosophy “to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals.”
We have published an annual report as an integrated report to enable deeper stakeholder understanding of Astellas’ efforts to continue to create value for Astellas held the following stakeholder dialogue with the aim of ascertaining expert opinions on selection of CSR core issues and medium-to long-term CSR activities that should be implemented.